Steroid nuclear receptor coactivator 2 controls immune tolerance by promoting induced T
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
17 06 2022
17 06 2022
Historique:
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
16
6
2022
Statut:
ppublish
Résumé
Steroid nuclear receptor coactivator 2 (SRC2) is a member of a family of transcription coactivators. While SRC1 inhibits the differentiation of regulatory T cells (T
Identifiants
pubmed: 35704583
doi: 10.1126/sciadv.abn7662
pmc: PMC9200286
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabn7662Subventions
Organisme : NIAID NIH HHS
ID : R01 AI109644
Pays : United States
Références
Nat Genet. 2001 Jan;27(1):20-1
pubmed: 11137993
Cell Signal. 2007 Jun;19(6):1101-12
pubmed: 17368849
PLoS Genet. 2017 Mar 8;13(3):e1006650
pubmed: 28273073
Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
pubmed: 22296764
J Immunol. 2019 Feb 1;202(3):760-769
pubmed: 30567733
EMBO J. 2006 Jan 11;25(1):108-17
pubmed: 16362036
Mol Endocrinol. 2015 Apr;29(4):502-17
pubmed: 25647480
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16701-6
pubmed: 12481024
Cell Mol Immunol. 2017 Dec;14(12):1013-1016
pubmed: 29082917
Cancer Immunol Res. 2016 Sep 2;4(9):721-5
pubmed: 27590281
Nat Commun. 2011;2:269
pubmed: 21468021
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
Front Immunol. 2012 Mar 21;3:51
pubmed: 22566933
Cell. 2010 Sep 17;142(6):914-29
pubmed: 20850013
Proc Natl Acad Sci U S A. 2016 May 3;113(18):4970-5
pubmed: 27084884
Immunity. 2009 May;30(5):626-35
pubmed: 19464985
Immunity. 2008 Jan;28(1):112-21
pubmed: 18199418
Cell Res. 2017 Jan;27(1):109-118
pubmed: 27995907
Nat Immunol. 2019 Feb;20(2):232-242
pubmed: 30643266
J Immunol. 2012 Jun 1;188(11):5337-47
pubmed: 22539794
Immunity. 2008 Jan;28(1):100-11
pubmed: 18199417
Cells. 2019 Aug 20;8(8):
pubmed: 31434282
Nat Immunol. 2008 Feb;9(2):194-202
pubmed: 18157133
Nat Genet. 2001 Jan;27(1):68-73
pubmed: 11138001
J Exp Med. 2015 Sep 21;212(10):1623-40
pubmed: 26304965
EMBO J. 2001 Nov 1;20(21):6071-83
pubmed: 11689447
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15161-6
pubmed: 10611355
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E458-E467
pubmed: 29282318
Nat Commun. 2021 Jan 4;12(1):76
pubmed: 33397953
Cancer Res. 2017 Aug 15;77(16):4293-4304
pubmed: 28611048
Sci Rep. 2021 Feb 9;11(1):3441
pubmed: 33564037
Nat Genet. 2001 Jan;27(1):18-20
pubmed: 11137992
Cell. 2014 Aug 14;158(4):734-748
pubmed: 25126782
Front Endocrinol (Lausanne). 2021 Feb 01;11:624122
pubmed: 33597928
Mol Cell Biol. 2010 Oct;30(19):4564-74
pubmed: 20679482
Cell Rep. 2020 Nov 3;33(5):108328
pubmed: 33147449
Nat Rev Clin Oncol. 2019 Jun;16(6):356-371
pubmed: 30705439
Neurosci Lett. 2014 Jan 24;559:50-5
pubmed: 24291696
Immunity. 2006 Sep;25(3):349-60
pubmed: 16979567
Immunity. 2009 May;30(5):636-45
pubmed: 19464986
Mol Cell Endocrinol. 2012 Jan 30;348(2):430-9
pubmed: 21664237
Nat Immunol. 2015 Jun;16(6):628-34
pubmed: 25939024
Mol Cell. 2006 Feb 17;21(4):555-64
pubmed: 16483936
Elife. 2014 Apr 25;3:e02057
pubmed: 24771768
Nature. 2008 May 8;453(7192):236-40
pubmed: 18368049
Mol Med. 2020 May 14;26(1):45
pubmed: 32410572
Int J Biol Sci. 2012;8(4):470-85
pubmed: 22419892
Mol Endocrinol. 2011 Dec;25(12):2041-53
pubmed: 22053001
J Clin Invest. 2020 Jun 1;130(6):3137-3150
pubmed: 32125291
Cell Rep. 2018 May 22;23(8):2318-2329
pubmed: 29791844
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11776-81
pubmed: 22753499